The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

Share Price Information for Inc&gwth Vct (IGV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.00
Bid: 68.50
Ask: 71.50
Change: 0.00 (0.00%)
Spread: 3.00 (4.38%)
Open: 70.00
High: 70.00
Low: 70.00
Prev. Close: 70.00
IGV Live PriceLast checked at -
The Income & Growth VCT is an Investment Trust

To provide an attractive return by maximising dividend distributions from the income and capital gains generated by investment in unquoted companies. This may include AIM companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement - 3rd Quarter

13 Aug 2019 15:19

RNS Number : 9065I
Income & Growth VCT (The) PLC
13 August 2019
 

The Income & Growth VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2019

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2019. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 30 June 2019

At 31 March 2019

 

Net assets attributable to shareholders

£84,211,371

£81,438,038

Shares in issue

103,827,380

104,363,865

Net asset value (NAV) per share

81.11p*

78.03p

Cumulative dividends paid to date per share

111.50p*

111.50p

Total return per share since inception (NAV basis)

192.61p

189.53p

*Figures are quoted prior to the 1.50 pence dividend referred to below.

 

INTERIM DIVIDEND

 

The Board declared an interim dividend of 1.50 pence per share for the year ending 30 September 2019, comprising 1.00 penny and 0.50 pence from capital. This dividend was paid to shareholders on 12 July 2019 to shareholders on the Register on 14 June 2019 and brings cumulative dividends paid per share to 113.00 pence per share, and also reduces the Company's Net Asset Value by a corresponding amount.

 

SHARE BUYBACKS

 

On 5 June 2019, the Company purchased 300,000 of the Company's own ordinary shares at a price of 67.50 pence per share for cancellation.

 

On 7 June 2019, the Company purchased 236,485 of the Company's own ordinary shares at a price of 70.25 pence for cancellation.

 

After the period end, with effect from 1 August 2019, the Board changed its share buyback policy objective of maintaining the discount to Net Asset Value at which the Company's shares may trade in the market from approximately 10% or less, to approximately 5% or less. In pursuing this policy, the Board's priority will remain to ensure that it is acting prudently and in the interests of the remaining shareholders of the Company. Share buybacks will continue to be entirely at the Board's discretion and will be subject to the Company having sufficient funds available for such a purpose. They will also continue to be subject to prevailing market conditions, the Listing Rules and any applicable law and regulatory restrictions at the relevant time. Shares bought back in the market will ordinarily be cancelled.

 

INVESTMENT ACTIVITY

 

Investments during the period

On 13 May 2019, the Company invested £1.53 million into a new investee company, Arkk Consulting, which provides services and software to enable organisations to remain compliant with regulatory reporting requirements.

 

On 22 May 2019, the Company invested £0.93 million into a new investee company, Parsley Box, which is a UK direct to consumer supplier of home delivered ambient ready meals for the elderly.

 

Realisations during the period

On 10 May 2019, the Company sold its remaining investment in Plastic Surgeon to Polygon Group for £1.22 million. Over the eleven years this investment was held, it generated proceeds of £2.27 million compared to an original investment cost £0.41 million, which is a multiple on cost of 5.6 x and an IRR of 20.5%.

 

On 28 June 2019, the Company sold its investment in ASL Technology for £4.79 million. Over the eight and a half years this investment was held, it generated proceeds of £5.94 million compared to an original investment cost of £2.72 million, which is a multiple on cost of 2.2x and an IRR of 12.6%.

 

Transactions after the period end

After the period end, the Company made a follow-on investment of £0.62 million into MPB Group, a leading online marketplace for camera and video equipment.

 

On 2 August 2019, £0.17 million of contingent consideration was received as part of the sale of Entanet Holdings in August 2017.

On 6 June 2019, the Company realised part of its investment in Master Removers Group generating proceeds receivable of £0.51 million, as part of a transaction which also increased the Company's equity interest from 6.3% to 9.6%.

 

PLANNED FUNDRAISING

As announced recently, the Board intends to launch offers for subscription for new ordinary shares in the autumn, full details of which will be contained in the prospectus that will be sent to all registered shareholders.

 

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

 

For further information, please contact:

Rob Brittain, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUORSRKKAWAAR
Date   Source Headline
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Mar 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
29th Feb 20242:00 pmRNSResult of Annual General Meeting
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
27th Feb 20249:30 amRNSInterim Management Statement
1st Feb 202411:35 amRNSVoting Rights and Capital
22nd Jan 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20249:04 amRNSAnnual Financial Report
2nd Jan 20242:30 pmRNSVoting Rights and Capital
1st Dec 20237:00 amRNSTotal Voting Rights
8th Nov 202310:20 amRNSDirector/PDMR Shareholding
8th Nov 202310:15 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20234:00 pmRNSTransaction in Own Shares
25th Sep 202311:00 amRNSDividend Declaration
20th Sep 20233:30 pmRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:02 pmRNSTransaction in Own Shares
14th Jun 20237:00 amRNSHalf-year Report
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20235:15 pmRNSDirector/PDMR Shareholding
26th May 20235:00 pmRNSIssue of Equity and Total Voting Rights
26th May 20234:36 pmRNSNet Asset Value(s)
2nd May 202310:00 amRNSTotal Voting Rights
13th Apr 20231:00 pmRNSDividend Declaration
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202311:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment:Tharstern Group Limited
3rd Mar 20235:04 pmRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:30 pmRNSInterim Management Statement
22nd Feb 20233:15 pmRNSResult of AGM
7th Feb 20237:01 amRNSDirector/PDMR Shareholding
7th Feb 20237:00 amRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:14 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
11th Jan 20235:34 pmRNSTransaction in Own Shares
19th Dec 20227:00 amRNSAnnual Financial Report
13th Dec 20223:47 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.